Cargando…

Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we include demographic factors, health-related behaviours and cardiovascular disease histor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Acebo, Inés, Dierssen-Sotos, Trinidad, de Pedro, María, Pérez-Gómez, Beatriz, Castaño-Vinyals, Gemma, Fernández-Villa, Tania, Palazuelos-Calderón, Camilo, Amiano, Pilar, Etxeberria, Jaione, Benavente, Yolanda, Fernández-Tardón, Guillermo, Salcedo-Bellido, Inmaculada, Capelo, Rocío, Peiró, Rosana, Marcos-Gragera, Rafael, Huerta, José M., Tardón, Adonina, Barricarte, Aurelio, Altzibar, Jone-Miren, Alonso-Molero, Jessica, Dávila-Batista, Verónica, Aragonés, Nuria, Pollán, Marina, Kogevinas, Manolis, Llorca, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150967/
https://www.ncbi.nlm.nih.gov/pubmed/30241493
http://dx.doi.org/10.1186/s12889-018-6019-z
_version_ 1783357074290245632
author Gómez-Acebo, Inés
Dierssen-Sotos, Trinidad
de Pedro, María
Pérez-Gómez, Beatriz
Castaño-Vinyals, Gemma
Fernández-Villa, Tania
Palazuelos-Calderón, Camilo
Amiano, Pilar
Etxeberria, Jaione
Benavente, Yolanda
Fernández-Tardón, Guillermo
Salcedo-Bellido, Inmaculada
Capelo, Rocío
Peiró, Rosana
Marcos-Gragera, Rafael
Huerta, José M.
Tardón, Adonina
Barricarte, Aurelio
Altzibar, Jone-Miren
Alonso-Molero, Jessica
Dávila-Batista, Verónica
Aragonés, Nuria
Pollán, Marina
Kogevinas, Manolis
Llorca, Javier
author_facet Gómez-Acebo, Inés
Dierssen-Sotos, Trinidad
de Pedro, María
Pérez-Gómez, Beatriz
Castaño-Vinyals, Gemma
Fernández-Villa, Tania
Palazuelos-Calderón, Camilo
Amiano, Pilar
Etxeberria, Jaione
Benavente, Yolanda
Fernández-Tardón, Guillermo
Salcedo-Bellido, Inmaculada
Capelo, Rocío
Peiró, Rosana
Marcos-Gragera, Rafael
Huerta, José M.
Tardón, Adonina
Barricarte, Aurelio
Altzibar, Jone-Miren
Alonso-Molero, Jessica
Dávila-Batista, Verónica
Aragonés, Nuria
Pollán, Marina
Kogevinas, Manolis
Llorca, Javier
author_sort Gómez-Acebo, Inés
collection PubMed
description BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we include demographic factors, health-related behaviours and cardiovascular disease history. METHODS: Four thousand sixtyparticipants were selected using a pseudorandom number list from Family Practice lists in 12 Spanish provinces. They completed a face-to-face computerized interview on their NSAID consumption, demographic characteristics, body mass index, alcohol and tobacco consumption and medical history. In addition, participants completed a self-administered food-frequency and alcohol consumption questionnaire. Factors associated with ever and current NSAID consumption were identified by logistic regression. RESULTS: Women consumed more non-aspirin NSAIDs (38.8% [36.7–41.0]) than men (22.3 [20.5–24.2]), but men consumed more aspirin (11.7% [10.3–13.2]) than women (5.2% [4.3–6.3]). Consumption of non-aspirin NSAIDs decrease with age from 44.2% (39.4–49.1) in younger than 45 to 21.1% (18.3–24.2) in older than 75, but the age-pattern for aspirin usage was the opposite. Aspirin was reported by about 11% patients, as being twice as used in men (11.7%) than in women (5.2%); its consumption increased with age from 1.7% (< 45 years old) to 12.4% (≥75 years old). Aspirin was strongly associated with the presence of cardiovascular risk factors or established cardiovascular disease, reaching odds ratios of 15.2 (7.4–31.2) in women with acute coronary syndrome, 13.3 (6.2–28.3) in women with strokes and 11.1 (7.8–15.9) in men with acute coronary syndrome. Participants with cardiovascular risk factors or diseases consumed as much non-aspirin NSAID as participants without such conditions. CONCLUSIONS: Non-aspirin NSAIDs were more consumed by women and aspirin by men. The age patterns of aspirin and non-aspirin NSAIDs were opposite: the higher the age, the lower the non-aspirin NSAIDs usage and the higher the aspirin consumption. People with cardiovascular risk factors or diseases consumed more aspirin, but they did not decrease their non-aspirin NSAIDs usage. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12889-018-6019-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6150967
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61509672018-09-26 Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study Gómez-Acebo, Inés Dierssen-Sotos, Trinidad de Pedro, María Pérez-Gómez, Beatriz Castaño-Vinyals, Gemma Fernández-Villa, Tania Palazuelos-Calderón, Camilo Amiano, Pilar Etxeberria, Jaione Benavente, Yolanda Fernández-Tardón, Guillermo Salcedo-Bellido, Inmaculada Capelo, Rocío Peiró, Rosana Marcos-Gragera, Rafael Huerta, José M. Tardón, Adonina Barricarte, Aurelio Altzibar, Jone-Miren Alonso-Molero, Jessica Dávila-Batista, Verónica Aragonés, Nuria Pollán, Marina Kogevinas, Manolis Llorca, Javier BMC Public Health Research Article BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we include demographic factors, health-related behaviours and cardiovascular disease history. METHODS: Four thousand sixtyparticipants were selected using a pseudorandom number list from Family Practice lists in 12 Spanish provinces. They completed a face-to-face computerized interview on their NSAID consumption, demographic characteristics, body mass index, alcohol and tobacco consumption and medical history. In addition, participants completed a self-administered food-frequency and alcohol consumption questionnaire. Factors associated with ever and current NSAID consumption were identified by logistic regression. RESULTS: Women consumed more non-aspirin NSAIDs (38.8% [36.7–41.0]) than men (22.3 [20.5–24.2]), but men consumed more aspirin (11.7% [10.3–13.2]) than women (5.2% [4.3–6.3]). Consumption of non-aspirin NSAIDs decrease with age from 44.2% (39.4–49.1) in younger than 45 to 21.1% (18.3–24.2) in older than 75, but the age-pattern for aspirin usage was the opposite. Aspirin was reported by about 11% patients, as being twice as used in men (11.7%) than in women (5.2%); its consumption increased with age from 1.7% (< 45 years old) to 12.4% (≥75 years old). Aspirin was strongly associated with the presence of cardiovascular risk factors or established cardiovascular disease, reaching odds ratios of 15.2 (7.4–31.2) in women with acute coronary syndrome, 13.3 (6.2–28.3) in women with strokes and 11.1 (7.8–15.9) in men with acute coronary syndrome. Participants with cardiovascular risk factors or diseases consumed as much non-aspirin NSAID as participants without such conditions. CONCLUSIONS: Non-aspirin NSAIDs were more consumed by women and aspirin by men. The age patterns of aspirin and non-aspirin NSAIDs were opposite: the higher the age, the lower the non-aspirin NSAIDs usage and the higher the aspirin consumption. People with cardiovascular risk factors or diseases consumed more aspirin, but they did not decrease their non-aspirin NSAIDs usage. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12889-018-6019-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-21 /pmc/articles/PMC6150967/ /pubmed/30241493 http://dx.doi.org/10.1186/s12889-018-6019-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gómez-Acebo, Inés
Dierssen-Sotos, Trinidad
de Pedro, María
Pérez-Gómez, Beatriz
Castaño-Vinyals, Gemma
Fernández-Villa, Tania
Palazuelos-Calderón, Camilo
Amiano, Pilar
Etxeberria, Jaione
Benavente, Yolanda
Fernández-Tardón, Guillermo
Salcedo-Bellido, Inmaculada
Capelo, Rocío
Peiró, Rosana
Marcos-Gragera, Rafael
Huerta, José M.
Tardón, Adonina
Barricarte, Aurelio
Altzibar, Jone-Miren
Alonso-Molero, Jessica
Dávila-Batista, Verónica
Aragonés, Nuria
Pollán, Marina
Kogevinas, Manolis
Llorca, Javier
Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
title Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
title_full Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
title_fullStr Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
title_full_unstemmed Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
title_short Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
title_sort epidemiology of non-steroidal anti-inflammatory drugs consumption in spain. the mcc-spain study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150967/
https://www.ncbi.nlm.nih.gov/pubmed/30241493
http://dx.doi.org/10.1186/s12889-018-6019-z
work_keys_str_mv AT gomezaceboines epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT dierssensotostrinidad epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT depedromaria epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT perezgomezbeatriz epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT castanovinyalsgemma epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT fernandezvillatania epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT palazueloscalderoncamilo epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT amianopilar epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT etxeberriajaione epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT benaventeyolanda epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT fernandeztardonguillermo epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT salcedobellidoinmaculada epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT capelorocio epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT peirorosana epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT marcosgragerarafael epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT huertajosem epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT tardonadonina epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT barricarteaurelio epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT altzibarjonemiren epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT alonsomolerojessica epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT davilabatistaveronica epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT aragonesnuria epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT pollanmarina epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT kogevinasmanolis epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy
AT llorcajavier epidemiologyofnonsteroidalantiinflammatorydrugsconsumptioninspainthemccspainstudy